GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hyundai Pharmaceutical Co Ltd (XKRX:004310) » Definitions » Ending Cash Position

Hyundai Pharmaceutical Co (XKRX:004310) Ending Cash Position : ₩9,136 Mil (As of May. 2024)


View and export this data going back to 1978. Start your Free Trial

What is Hyundai Pharmaceutical Co Ending Cash Position?

Hyundai Pharmaceutical Co's Ending Cash Position for the quarter that ended in May. 2024 was ₩9,136 Mil.

Hyundai Pharmaceutical Co's quarterly Ending Cash Position declined from Nov. 2023 (₩16,203 Mil) to Feb. 2024 (₩12,664 Mil) and declined from Feb. 2024 (₩12,664 Mil) to May. 2024 (₩9,136 Mil).

Hyundai Pharmaceutical Co's annual Ending Cash Position increased from Nov. 2021 (₩21,628 Mil) to Nov. 2022 (₩30,266 Mil) but then declined from Nov. 2022 (₩30,266 Mil) to Nov. 2023 (₩16,203 Mil).

Hyundai Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Hyundai Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyundai Pharmaceutical Co Ending Cash Position Chart

Hyundai Pharmaceutical Co Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,404.53 13,272.35 21,628.10 30,266.15 16,203.43

Hyundai Pharmaceutical Co Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23,159.77 16,470.64 16,203.43 12,663.59 9,136.26

Hyundai Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Hyundai Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Nov. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=30266.152+-14062.726
=16,203

Hyundai Pharmaceutical Co's Ending Cash Position for the quarter that ended in May. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=12663.586+-3527.322
=9,136

Hyundai Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Hyundai Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyundai Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hyundai Pharmaceutical Co Ltd (XKRX:004310) » Definitions » Ending Cash Position
Comparable Companies
XKRX:002800 XKRX:002720 XKRX:183490 XKRX:063160 XKRX:072020 XKRX:067290 XKRX:000230 XKRX:106190 XKRX:009300 XKRX:330350 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Bonegeunsa Street 135, Hyundai Pharm Building, Gangnam-gu, Seoul, KOR, 135-545
Website
http://www.hyundaipharm.co.kr
Hyundai Pharmaceutical Co Ltd is a South Korea based company engage in the manufacturing and distribution of pharmaceutical products, health foods, and medical equipment.

Hyundai Pharmaceutical Co Headlines

No Headlines